Intravenous tissue plasminogen activator, ischemic stroke, and the risk of Kounis Syndrome

被引：2
|
作者：
Kounis, Nicholas G. [1 ]
Kouni, Sophia N. [1 ]
Kounis, George N. [1 ]
Kounis, Sophia A. [1 ]
机构：
[1] Patras Highest Inst Educ & Technol, Dept Med Sci, Patras 26221, Greece
来源：
ANNALS OF INDIAN ACADEMY OF NEUROLOGY | 2011年 / 14卷 / 03期
关键词：
MYOCARDIAL-INFARCTION;
D O I：
10.4103/0972-2327.85913
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：223 / U86
页数：2
相关论文
共 50 条
  • [31] The economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke
    Demaerschalk, B
    Yip, T
    STROKE, 2004, 35 (01) : 298 - 298
  • [32] Quantitative electroencephalograph in acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator
    Yang, Juan
    Zhao, Xiaohui
    Bai, Qingke
    Zhao, Zhengguo
    Sui, Haijing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (01): : 507 - 514
  • [33] Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
    Sadeghi-Hokmabadi, Elyar
    Farhoudi, Mehdi
    Taheraghdam, Aliakbar
    Hashemilar, Mazyar
    Savadi-Osguei, Daryous
    Rikhtegar, Reza
    Mehrvar, Kaveh
    Sharifipour, Ehsan
    Youhanaee, Parisa
    Mirnour, Reshad
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2016, 9 : 361 - 367
  • [34] Antiplatelet therapy and the risk of intracranial hemorrhage after intravenous tissue plasminogen activator therapy for acute ischemic stroke
    Hallevi, Hen
    Grotta, James C.
    ARCHIVES OF NEUROLOGY, 2008, 65 (05) : 575 - 576
  • [35] The Role of Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke With Large Vessel Occlusion
    Ooi, Yinn Cher
    Mukarram, Faisal
    Tristan, Honda
    Kaneko, Naoki
    Nour, May
    Colby, Geoffrey
    Tateshima, Satoshi
    Jahan, Reza
    Duckwiler, Gary
    Liebeskind, David
    Saver, Jeffrey
    Szeder, Viktor
    STROKE, 2020, 51
  • [36] Experience with intravenous tissue plasminogen activator in acute ischemic stroke in a community health setting
    Agarwal, P
    Sen, S
    NEUROLOGY, 2001, 56 (08) : A436 - A436
  • [37] Seasonal difference in the incidence of ischemic stroke patients treated with intravenous tissue plasminogen activator
    Kodera, Y.
    Yutani, S.
    Mizuma, A.
    Uesugi, T.
    Tokuoka, K.
    Ohnuki, Y.
    Nagata, E.
    Takahashi, W.
    Takizawa, S.
    Kitagawa, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 67 - 67
  • [38] Intravenous tissue plasminogen activator for acute ischemic stroke - A Canadian hospital's experience
    Chapman, KM
    Woolfenden, AR
    Graeb, D
    Johnston, DCC
    Beckman, J
    Schulzer, M
    Teal, PA
    STROKE, 2000, 31 (12) : 2920 - 2924
  • [39] Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada
    Demaerschalk, BM
    Silver, B
    Merino, JG
    Wong, E
    Hill, MD
    Poncha, F
    Foell, B
    Tamayo, A
    Buchan, AM
    Hachinski, V
    STROKE, 2003, 34 (01) : 248 - 249
  • [40] Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients
    Satoru Takeuchi
    Kojiro Wada
    Kimihiro Nagatani
    Naoki Otani
    Hideo Osada
    Hiroshi Nawashiro
    Acta Neurochirurgica, 2012, 154 : 87 - 87
12345